Terazosin and Parkinson's Disease Extension Study
Terazosin and Parkinson's Disease Extension Study
Active, not recruiting · NCT05109364 · Registry updated 2026-03-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Terazosin and Parkinson's Disease Extension Study | Nerve Degeneration, Parasomnias, Parkinson disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, REM Sleep Parasomnias, REM sleep behavior disorder, autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, primary dysautonomia, psychiatric disorder, secondary Parkinson disease, sleep-wake disorder, synucleinopathy | Active, not recruiting | Phase 2 | 2026-03-02 | NCT05109364 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cedars-Sinai Medical Center | 161 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars Sinai Medical Center | Los Angeles | United States | 135 |